The gut bacteria discovery that made me rethink everything
The short answer: Researchers have identified a gut bacteria called CAG-170 that appears at higher levels in people with Crohn's disease. It's not a diagnosis tool yet, and it won't change your prescription — but it does give us a clearer picture of what's happening in the gut microbiome, and it opens important conversations about how we support it alongside medical care.
Now let me tell you why this stopped me mid-coffee on a Tuesday morning.
---
## What is CAG-170, and why does it matter for Crohn's?
CAG-170 is a newly characterised gut bacteria — part of a broader scientific effort to map the thousands of microorganisms that live in the human digestive tract. For most of medical history, we simply didn't have the tools to identify many of them. Next-generation DNA sequencing has changed that dramatically in the last decade.
In studies examining the gut microbiomes of people with Crohn's disease, CAG-170 has shown up at notably higher levels compared to healthy controls. Researchers believe it may play a role in sustaining gut inflammation — not as the single cause of Crohn's, but as one of potentially several microbial contributors that keep the inflammatory cycle going.
Key takeaway: CAG-170 doesn't cause Crohn's on its own, but its elevated presence in Crohn's patients suggests the microbiome isn't just a bystander in this disease — it may be an active participant in inflammation.
This matters because it shifts how we think about gut support. It's not just about avoiding trigger foods or reducing stress (though both still matter). It's about the actual microbial ecosystem in the gut — and whether we're giving it what it needs to move toward balance.

---
## What this research does NOT mean
Before I go further, I want to be really clear — because I've seen research like this get twisted into fear-based claims online, and that's not what we do here.
This research does not mean:
- That CAG-170 is the cause of your Crohn's
- That targeting this bacteria with supplements will put you in remission
- That you should change, reduce, or stop any medication
- That your medical team has been missing something obvious
What it does mean is that the science of the gut microbiome in Crohn's is advancing quickly. And as the Crohn's & Colitis Foundation has long noted, the relationship between gut bacteria and IBD inflammation is one of the most active areas of research in the field right now. We are learning, year by year, that the microbiome is far more complex — and far more relevant — than we once thought.
For families like mine, that's not frightening. It's actually hopeful.
---
## What I think about when I read research like this
When my son was diagnosed, one of the things that struck me most — both as his mum and as a naturopath — was how little attention was paid to his gut microbiome in the early days of his treatment. The focus was (rightly) on getting the inflammation under control. But the question of why his gut environment had become so inflamed felt like it was left hanging.
My husband's story is different — he was diagnosed young, had three surgeries with complications, and has now been in deep remission for over 20 years with no flares. What changed for him wasn't one single thing. It was a slow, careful rebuilding of how he ate, how he moved, how he managed stress, and yes — how he supported his gut microbiome alongside his ongoing medical care.
I can't tell you that CAG-170 was part of his story. We didn't have that language then. But I can tell you that paying attention to the microbial environment in the gut — through food, through targeted support, through working closely with his gastroenterologist — was part of what helped him get to where he is today.
Research like this validates that instinct.

---
## What this means practically — as a naturopath and a Crohn's mum
So what do we actually do with this information? Here's how I think about it in clinic and at home.
1. Microbiome diversity still matters — maybe more than we knew
Research consistently shows that people with Crohn's tend to have lower microbial diversity in their gut — fewer species, less balance. The presence of bacteria like CAG-170 may partly be a consequence of that reduced diversity. Supporting diversity through a wide range of plant foods (within your tolerance), fermented foods where appropriate, and targeted probiotic support is still one of the most evidence-informed things we can do.
According to the NIH Human Microbiome Project, the gut microbiome can begin to shift in response to dietary changes within days — which is both encouraging and a reminder of how dynamic this system is.
2. This is a conversation to have with your gastroenterologist
If you've been curious about microbiome testing, or if your gut symptoms feel out of proportion to what your scopes are showing, this research gives you a concrete starting point for a conversation. Ask your GI team what they know about microbiome research in IBD. A good gastroenterologist will welcome the question.
3. Naturopathic support is about the environment, not the enemy
From a naturopathic perspective, we're not trying to 'kill' CAG-170 or any single bacteria. We're trying to create a gut environment where beneficial bacteria can thrive and the conditions for dysbiosis are reduced. That means looking at the whole picture: food quality, digestive function, stress response, sleep, and any nutritional gaps that might be affecting the gut lining.
4. Early screening remains one of the most powerful tools we have
This is something I say often, and I'll keep saying it: if Crohn's runs in your family, please talk to your GP about early screening for your children. Blood markers and fecal calprotectin testing can be done from around age 10. The earlier we catch inflammation, the more options we have — and the less damage accumulates before treatment begins.

---
## Common questions
Q: Should I ask my doctor to test for CAG-170?
CAG-170 is currently identified through research-grade microbiome sequencing, not standard clinical testing. It's not yet part of routine Crohn's diagnosis or monitoring — but the conversation about microbiome health with your gastroenterologist is always worth having.
Q: Will probiotics fix a CAG-170 imbalance?
There's no probiotic currently formulated to target CAG-170 specifically. General probiotic and prebiotic support may help improve overall microbiome diversity, but always discuss new supplements with your GI team, especially if you're on immunosuppressants.
Q: Does this change how Crohn's is treated?
Not yet in terms of standard medical treatment. But it does strengthen the case for integrating microbiome-focused support alongside conventional care — which is exactly the approach we take at The Crohn's Method.
Q: My child has Crohn's. Should I be worried about this?
This research is a reason for curiosity and conversation, not alarm. Focus on what you can support: a varied, whole-food diet within their tolerance, good sleep, stress management, and a strong relationship with their gastroenterology team. And if you haven't already, ask about fecal calprotectin monitoring as part of their ongoing care.
---
The science of Crohn's is moving fast. And while no single discovery is a magic answer, each one gives us a slightly clearer map of what's happening — and what we can do to support the journey.
As always, this supports your medical care. It doesn't replace it.
— Kate
Naturopath. Crohn's mum. The Crohn's Method.